Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Interest & Investment Income (2022 - 2023)

Envoy Medical's Interest & Investment Income history spans 2 years, with the latest figure at $528297.0 for Q2 2023.

  • On a quarterly basis, Interest & Investment Income fell 6.23% to $528297.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $9.4 million, a N/A change, with the full-year FY2022 number at $6.1 million, up 16161.88% from a year prior.
  • Interest & Investment Income hit $528297.0 in Q2 2023 for Envoy Medical, down from $3.4 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for COCH hit a ceiling of $3.6 million in Q4 2022 and a floor of $40410.0 in Q1 2022.